X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-05 | GTHX | Perry Andrew | Chief Commercial Officer | S - Sale | $2.51 | -1,337 | 112,614 | -1% | -$3,353 | ||||||
2024-07-05 | GTHX | Murdock Terry L | COO | S - Sale | $2.51 | -2,475 | 128,012 | -2% | -$6,207 | ||||||
2024-07-05 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale | $2.51 | -2,475 | 159,312 | -2% | -$6,207 | ||||||
2024-07-05 | GTHX | Avagliano Mark | Chief Business Officer | S - Sale | $2.51 | -2,638 | 242,045 | -1% | -$6,615 | ||||||
2024-07-05 | GTHX | Umstead John W. V | CFO | S - Sale | $2.51 | -527 | 187,718 | 0% | -$1,322 | ||||||
2024-07-05 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale | $2.51 | -7,662 | 549,674 | -1% | -$19,214 | ||||||
2024-05-23 | GTHX | Thomas Monica R. | Chief Legal, People Officer | S - Sale | $4.27 | -5,826 | 109,825 | -5% | -$24,864 | ||||||
2024-05-13 | GTHX | Umstead John W. V | CFO | S - Sale | $4.79 | -8,151 | 153,245 | -5% | -$39,034 | ||||||
2024-05-13 | GTHX | Murdock Terry L | COO | S - Sale | $4.79 | -8,151 | 95,487 | -8% | -$39,034 | ||||||
2024-05-13 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale | $4.79 | -8,151 | 161,787 | -5% | -$39,034 | ||||||
2024-05-13 | GTHX | Avagliano Mark | Chief Business Officer | S - Sale | $4.79 | -8,151 | 209,683 | -4% | -$39,034 | ||||||
2024-05-13 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale | $4.79 | -37,258 | 452,336 | -8% | -$178,421 | ||||||
2024-03-18 | GTHX | Umstead John W. V | CFO | S - Sale | $3.02 | -6,547 | 123,896 | -5% | -$19,752 | ||||||
| D | 2024-02-12 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale+OE | $4.62 | -28,600 | 169,938 | -14% | -$132,143 | |||||
| DM | 2024-01-03 | GTHX | Umstead John W. V | CFO | S - Sale+OE | $3.09 | -743 | 130,443 | -1% | -$2,298 | |||||
| DM | 2024-01-03 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale+OE | $3.08 | -3,740 | 169,938 | -2% | -$11,537 | |||||
| D | 2024-01-03 | GTHX | Perry Andrew | Chief Commercial Officer | S - Sale+OE | $3.12 | -2,413 | 87,102 | -3% | -$7,526 | |||||
| D | 2024-01-03 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale+OE | $3.12 | -11,686 | 489,594 | -2% | -$36,447 | |||||
| DM | 2024-01-03 | GTHX | Avagliano Mark | Chief Business Officer | S - Sale+OE | $3.09 | -4,081 | 117,834 | -3% | -$12,601 | |||||
| DM | 2024-01-03 | GTHX | Murdock Terry L | COO | S - Sale+OE | $3.08 | -3,740 | 103,638 | -3% | -$11,537 | |||||
2024-01-02 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale | $3.27 | -32,983 | 400,580 | -8% | -$108,006 | ||||||
| D | 2023-12-11 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale+OE | $3.41 | -33,839 | 136,378 | -20% | -$115,522 | |||||
| D | 2023-08-08 | GTHX | Velleca Mark A. | Dir | S - Sale+OE | $2.00 | -60,000 | 116,000 | -34% | -$119,974 | |||||
2023-07-05 | GTHX | Perry Andrew | Chief Commercial Officer | S - Sale | $2.45 | -355 | 55,945 | -1% | -$871 | ||||||
2023-07-05 | GTHX | Murdock Terry L | COO | S - Sale | $2.45 | -1,361 | 70,078 | -2% | -$3,339 | ||||||
2023-07-05 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale | $2.45 | -1,361 | 136,378 | -1% | -$3,339 | ||||||
2023-07-05 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale | $2.45 | -2,719 | 433,563 | -1% | -$6,672 | ||||||
| DM | 2023-01-04 | GTHX | Moses Jennifer K. | CFO | S - Sale+OE | $5.52 | -2,368 | 57,820 | -4% | -$13,080 | |||||
| DM | 2023-01-04 | GTHX | Murdock Terry L | COO | S - Sale+OE | $5.52 | -2,368 | 36,439 | -6% | -$13,080 | |||||
| D | 2023-01-04 | GTHX | Perry Andrew | Chief Commercial Officer | S - Sale+OE | $5.58 | -820 | 21,300 | -4% | -$4,572 | |||||
| DM | 2023-01-04 | GTHX | Malik Rajesh | Chief Medical Officer | S - Sale+OE | $5.52 | -2,368 | 102,739 | -2% | -$13,080 | |||||
| DM | 2023-01-04 | GTHX | Hanson James S. | GC | S - Sale+OE | $5.52 | -2,368 | 41,087 | -5% | -$13,080 | |||||
| DM | 2023-01-03 | GTHX | Bailey John E. (Jack) Jr. | Pres, CEO | S - Sale+OE | $5.81 | -37,626 | 276,282 | -12% | -$218,714 | |||||
| D | 2022-10-18 | GTHX | Velleca Mark A. | Dir | S - Sale+OE | $11.70 | -15,000 | 116,000 | -11% | -$175,490 | |||||
| D | 2022-09-20 | GTHX | Velleca Mark A. | Dir | S - Sale+OE | $13.50 | -20,000 | 116,000 | -15% | -$270,044 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |